Povidone iodine market seen reaching $242.2 million by 2031

Allied Market Research says the global povidone iodine market is on track to grow from $152.6 million in 2021 to $242.2 million by 2031, a 4.7% compound annual growth rate. The report points to product innovation, stronger antimicrobial performance and healthcare demand as key forces shaping the market.

Why it matters: - Povidone iodine remains a core antiseptic in healthcare, so growth in the market signals continued demand for infection prevention and wound-care products. - The market outlook also points to more investment in improved formulations, delivery systems and antimicrobial technologies. - A sample copy of the report is available from Allied Market Research.

What happened: - Allied Market Research published a report on the global povidone iodine market on June 11, 2026. - The report projects the market will reach $242.2 million by 2031. - The forecast implies 4.7% CAGR from 2022 to 2031. - The market was valued at $152.6 million in 2021.

The details: - The report covers revenue estimates, key investment opportunities, current trends, regional insights, market dynamics and the competitive landscape. - AMR says the study uses qualitative and quantitative analysis for historical and forecast periods. - The researchers use SWOT analysis and the Porter Five Forces model to assess competitive dynamics and growth prospects. - The report says that approach can help investors, organizations, shareholders and new entrants make strategic decisions. - Researchers are developing sustained-release PVP-I formulations, including liposome hydrogels, to extend antimicrobial activity. - Those formulations are designed to pair infection control with moisturization to support wound healing. - Innovations in PVP-I formulations have improved broad-spectrum antimicrobial activity against a wider range of pathogens. - That enhancement is especially relevant for healthcare settings focused on infection prevention and control. - The incorporation of nanotechnology has led to nanocomposite products such as PVP-I-coated carbon nanotube bandages. - These materials are intended to improve antimicrobial properties and speed wound healing.

Between the lines: - The report frames growth as a mix of steady demand and product-level innovation, rather than a sudden market shift. - Healthcare use cases appear to be driving most of the value, especially products tied to antisepsis and wound management. - The emphasis on formulation changes suggests competition may increasingly center on efficacy, delivery and convenience.

What's next: - AMR expects continued development of advanced formulations and delivery systems for PVP-I. - The report also points to ongoing competitive activity among market players, including mergers, partnerships, joint ventures and new product launches. - Recent examples include Avrio Health's February 2021 launch of Betadine Antiseptic Oral Rinse, which contains 0.5% povidone-iodine. - Mundipharma's October 2022 collaboration with Ecolab aimed to improve antiseptic solutions containing povidone iodine. - The report names companies including Avrio Health L.P., 3M Company, Thatcher Company, Nippon Shokubai Co., Ltd., BASF SE, Vishal Laboratories, Lasa Supergenerics Ltd, Samrat Pharmachem Limited, Luxica Pharma Inc. and Glide Chem Private Limited. - More details are available in the full summary report and the PR Newswire release.

The bottom line: - AMR sees a modest but durable growth path for povidone iodine, supported by healthcare demand and incremental product innovation.